🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

RecruitingNAAges 18 Years - anyAllMount Sinai Hospital, Canada
NCT06805669 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed written and voluntary informed consent. * Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic. * Age ≥ 18 years. * Have not received any previous systemic treatment with palliative intent for advanced sarcoma. * Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale. * Life expectancy \> 6 months. * Willing/able to complete questionnaires. Exclusion Criteria: * Clinical evidence of cognitive impairment that would preclude the ability to provide informed consent and complete questionnaires, at investigator´s discretion. * Patient in need of urgent home support services or symptom management through a palliative care team. * Patient is being actively followed by a palliative care physician. * Active psychiatric disorder or drug abuse. * Insufficient English literacy to complete questionnaires.
💊

What it tests

  • Early referral to palliative care
  • Standard Treatment
📍

Where

1 site
Mount Sinai Hospital
Toronto, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy